Stay updated on Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Sign up to get notified when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.

Latest updates to the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page
- Check4 days agoChange DetectedAdded a Locations section with a new site in Seattle, Washington. Washington is now listed as a study location.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page footer revision updated from v3.3.1 to v3.3.2; no other sections of the study details were altered.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page no longer displays the temporary operating status notice regarding funding. Core study information remains unchanged.SummaryDifference0.4%

- Check54 days agoChange DetectedThe new screenshot shows minor UI/layout adjustments to the study page. Core content such as the study title, NCT number, sponsor, eligibility criteria, enrollment numbers, and primary outcomes appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference4%

Stay in the know with updates to Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.